BMS-908662

DB12854InvestigationalSmall molecule

BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.

Mechanism: Pharmacologically active on RAF proto-oncogene serine/threonine-protein kinase and Serine/threonine-protein kinase B-raf
Curator reviewed
Formula / weight: C₂₄H₁₉ClN₄O₄ · 462.89 g/mol (avg)
Code names: BMS-908662

Resolves to

Compound

Structure

InChIKeyMMNNTJYFHUDSKL-UHFFFAOYSA-NSMILESCOC(=O)NC1=NC2=CC(=CC=C2N1)C1(O)N(C(=O)C2=CC=CC=C12)C1=CC(Cl)=CC=C1C

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-908662, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.